← Leaderboards
Winfred C Wang
St. Jude Children'S Research Hospital
$3,647,138
Attributed
$3,647,138
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.2M · FY2005–17$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$14,119,685 · 9
By mechanism
U54$13,552,141 · 7
N01$567,544 · 2
Top collaborators
No co-investigators on record.
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Patricia Michele Flynn$17,668,133
- Aditya H Gaur$5,475,552
Others in their field
Top investigators on “Sickle Cell Anemia”
- Russell E Ware · Duke University$48,435,687
- Michael Rutledge Debaun · Vanderbilt University Medical Center$38,268,866
- Martin H. Steinberg · Boston Medical Center$25,628,557
- Michael L. Terrin · Clinical Trials And Surveys Corporation$23,855,067
- Barbara L Kroner · Research Triangle Institute$21,141,016
- Garret A Fitzgerald · University Of Pennsylvania$20,602,198
Research focus
Sickle Cell AnemiaHydroxyureaCooperative StudyHuman SubjectHuman Therapy EvaluationMagnesiumBlood Disorder ChemotherapyCombination ChemotherapyClinical ResearchPatient Oriented ResearchStructureChildPharmaceutical PreparationsToxic EffectMultiple Organ FailureLongitudinal Human StudyCohortCollaborationsPathologic ProcessClinical Trial Phase IClinical Trial Phase IiInfant Human (0-1 Year)ChildhoodBrain
Grant awards (28)
BABY HUG FOLLOW-UP STUDY II$90,096
N01 · FY2017 · HL · contact PI
BABY HUG FOLLOW-UP STUDY II$395,243
N01 · FY2012 · HL · contact PI
Comprehensive Sickle Cell Center$2,331,457
U54 · FY2007 · HL · contact PI
Treatment with Hydroxyurea and Magnesium:A Prospective Phase III Clinical Trial$677,561
U54 · FY2007 · HL · contact PI
Combination Treatment with Hydroxyurea and Magnesium: Phase I & Phase II Studies$212,884
U54 · FY2007 · HL · contact PI
Sickle Cell Scholar's Program$1,887
U54 · FY2007 · HL · contact PI
Comprehensive Sickle Cell Center$1,977,867
U54 · FY2006 · HL · contact PI
Treatment with Hydroxyurea and Magnesium:A Prospective Phase III Clinical Trial$360,000
U54 · FY2006 · HL · contact PI
Comprehensive Sickle Cell Center$179,002
U54 · FY2006 · HL · contact PI
Combination Treatment with Hydroxyurea and Magnesium: Phase I & Phase II Studies$166,511
U54 · FY2006 · HL · contact PI
Sickle Cell Scholar's Program$1,000
U54 · FY2006 · HL · contact PI
Comprehensive Sickle Cell Center$2,051,280
U54 · FY2005 · HL
Treatment with Hydroxyurea and Magnesium:A Prospective Phase III Clinical Trial$360,000
U54 · FY2005 · HL
Comprehensive Sickle Cell Center$200,000
U54 · FY2005 · HL
Combination Treatment with Hydroxyurea and Magnesium: Phase I &Phase II Studies$163,140
U54 · FY2005 · HL
Sickle Cell Scholar's Program$1,000
U54 · FY2005 · HL
Comprehensive Sickle Cell Center$1,893,234
U54 · FY2004 · HL
Treatment with Hydroxyurea and Magnesium:A Prospective Phase III Clinical Trial$360,000
U54 · FY2004 · HL
Combination Treatment with Hydroxyurea and Magnesium: Phase I &Phase II Studies$158,391
U54 · FY2004 · HL
Sickle Cell Scholar's Program$1,000
U54 · FY2004 · HL
Comprehensive Sickle Cell Center$1,839,707
U54 · FY2003 · HL
Combination Treatment with Hydroxyurea and Magnesium:A Prospective Randomized Dou$360,000
U54 · FY2003 · HL
Combination Treatment with Hydroxyurea and Magnesium: Phase I &Phase II Studies$153,776
U54 · FY2003 · HL
Administrative Core$101,444
U54 · FY2003 · HL
Sickle Cell Scholar's Program$1,000
U54 · FY2003 · HL
PEDRIATRIC HYDROXYUREA PHASE III CLINICAL TRIAL CLINICAL$0
N01 · FY2001 · HB
PEDRIATRIC HYDROXYUREA PHASE III CLINICAL TRIAL CLINICAL$82,205
N01 · FY2000 · HB
PEDRIATRIC HYDROXYUREA PHASE III CLINICAL TRIAL CLINICAL$0
N01 · FY2000 · HB